logo

KNTE(Delisted)

KinnateยทNASDAQ
--
--(--)

KNTE Profile

Kinnate Biopharma Inc.

A clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer

--
--
12/03/2020
NASDAQ Stock Exchange
27
12-31
Common stock
103 Montgomery Street , Suite 150 , The Presidio of San Francisco , San Francisco , CA 94129
--
Kinnate Biopharma Inc., incorporated in Delaware. The company is a clinical-stage precision oncology company focused on discovering, designing and developing small molecule kinase inhibitors for difficult-to-treat, genome-defined cancers.